Ami-LC-MD clinical trials

A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies

This study is looking at a new way to give an existing cancer medicine, amivantamab, as an injection under the skin. It aims to find the safest and most effective dose for this new delivery method, for people with advanced solid cancers.